Nexstim Receives Order for Two NBT® Systems from Finnish University Hospital Customer
10 déc. 2021 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, December 10, 2021 at 9 AM (EET) Nexstim Receives Order for Two NBT® Systems from Finnish University Hospital Customer Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or...
OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response - A Free Webinar from the Brain & Behavior Research Foundation
07 déc. 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response”...
OWP Pharmaceuticals Announces IND Authorization for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
17 nov. 2021 08h00 HE
|
OWP Pharmaceuticals, Inc.
NAPERVILLE, Ill., Nov. 17, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Nexstim aloittaa yhteistyön suomalaisen yksityisklinikan kanssa ja etenee strategisissa tavoitteissaan
05 nov. 2021 03h00 HE
|
Nexstim Oyj
Lehdistötiedote, Helsinki, 5.11.2021 klo 9.00 (EET) Nexstim aloittaa yhteistyön suomalaisen yksityisklinikan kanssa ja etenee strategisissa tavoitteissaan Nexstim Oyj (NXTMH:HEX, NXTMS:STO)...
Nexstim engages in cooperation with private Finnish clinic and makes progress in its strategic goals
05 nov. 2021 03h00 HE
|
Nexstim Oyj
Press release, Helsinki, 5 November 2021 at 9 AM (EET) Nexstim engages in cooperation with private Finnish clinic and makes progress in its strategic goals Nexstim Plc (NXTMH:HEX, NXTMS:STO)...
Developing New Treatments for Mania Using Brain-Based Risk Markers - A Free Webinar from the Brain & Behavior Research Foundation
04 nov. 2021 08h59 HE
|
Brain & Behavior Research Foundation
New York, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Developing New Treatments for Mania Using Brain-Based Risk Markers” on...
Nexstim Releases the New NBS5+ in the United States
22 oct. 2021 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 22 October 2021 at 9 AM (EEST) Nexstim Releases the New NBS5+ in the United States Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the launch of a new...
Early-Life Risk for Pathological Anxiety - A Free Webinar from the Brain & Behavior Research Foundation
07 oct. 2021 09h09 HE
|
Brain & Behavior Research Foundation
New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Early-Life Risk for Pathological Anxiety” on Tuesday, October 12, 2021,...
Brain & Behavior Research Foundation Awards Over $10.3 Million In Young Investigator Grants to 150 Mental Health Scientists
06 oct. 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation today announced its annual Young Investigator Grants, valued at more than $10.3 million, awarded to 150 of...
2021 Pardes Humanitarian Prize in Mental Health Awarded to Three Women Striving to Improve Treatment, Expand Access and Empower People with Psychiatric Illness
28 sept. 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation today announced that three extraordinary women who are advocates for mental health and live with mental...